atf7ip Antibody

Biological Function of ATF7IP

ATF7IP regulates gene expression by recruiting histone methyltransferases (e.g., SETDB1) to specific loci, enabling H3K9me3 deposition. Key findings include:

• Immune Regulation:

  • Inhibits IL2 gene expression in T cells by silencing the Il2-Il21 intergenic region .

  • Deficiency in T cells impairs Th17 differentiation and enhances IL-2 production, linked to autoimmune disease susceptibility .

• Cancer Biology:

  • Suppresses transposable elements (TEs) and retroviral sequences, preventing genomic instability .

  • Inhibition of ATF7IP–SETDB1 complexes enhances tumor antigen presentation and antitumor immunity in cancer models .

• Hematopoiesis:

  • Maintains hematopoietic stem cell (HSC) function by regulating chromatin accessibility and H3K9me3 deposition .

Research Applications of ATF7IP Antibodies

Antibodies are critical for studying ATF7IP’s subcellular localization, protein interactions, and functional roles:

Therapeutic Implications

• Autoimmune Diseases: Targeting ATF7IP to modulate IL-2 production may alleviate autoimmunity .

• Cancer Immunotherapy: Inhibiting ATF7IP–SETDB1 complexes enhances tumor antigen presentation, boosting antitumor immunity .